Bottom line
JDOC vs HGHAX: the short answer
JDOC (JPMorgan Healthcare Leaders ETF) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 61% by weight.
JDOC is cheaper at 0.65% vs 1.33% — a difference of $68 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
JDOC vs HGHAX side by side
| JDOC | HGHAX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | J.P. Morgan | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.65% | 1.33% |
| Annual cost per $10k | $65 | $133 |
| 10-yr cost on $10k (prospectus) | $810 | $2,063 |
| Max front load | None | 5.5% |
| 12b-1 fee | — | 0.25% |
| 1-yr return | +14.9% | — |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +11.3% | +20.9% |
| Worst quarter | −11.9% | −15.7% |
| Net assets (fund) | $9.1M | $772.2M |
| Number of holdings | 61 | 80 |
| Portfolio turnover | 92% | 49% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JDOC | HGHAX | Difference |
|---|---|---|---|
| 2025 | +14.9% | +15.6% | −0.7% |
| 2024 | −0.6% | 0.0% | −0.6% |
Source: Fund prospectus bar charts
Holdings overlap
16 of JDOC's top 25 holdings also appear in HGHAX's top 25.
| Holding | JDOC | HGHAX |
|---|---|---|
| AbbVie, Inc. | 7.85% | 4.21% |
| Eli Lilly & Co. | 7.76% | 12.03% |
| UnitedHealth Group, Inc. | 5.85% | 4.74% |
| Merck & Co., Inc. | 4.82% | 6.00% |
| Johnson & Johnson | 4.82% | 6.75% |
| Thermo Fisher Scientific, Inc. | 3.73% | 1.58% |
| Abbott Laboratories | 3.11% | 1.82% |
| CVS Health Corp. | 2.83% | 2.84% |
| GSK plc | 2.47% | 1.17% |
| Stryker Corp. | 2.23% | 1.24% |
| Danaher Corp. | 2.16% | 2.57% |
| Cencora, Inc. | 2.07% | 2.46% |
| Intuitive Surgical, Inc. | 1.93% | 2.88% |
| Edwards Lifesciences Corp. | 1.73% | 2.48% |
| Regeneron Pharmaceuticals, Inc. | 1.60% | 2.02% |
Source: SEC Form N-PORT
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between JDOC and HGHAX?
Which is cheaper, JDOC or HGHAX?
Should I own both JDOC and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.